2
4
4
REMEDY Act
8/12/2025, 3:23 AM
Summary of Bill S 2620
The bill "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications" was introduced in the 119th Congress on July 31, 2025.
Read the Full Bill
Current Status of Bill S 2620
Bill S 2620 is currently in the status of Bill Introduced since July 31, 2025. Bill S 2620 was introduced during Congress 119 and was introduced to the Senate on July 31, 2025. Bill S 2620's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5000: 1) as of July 31, 2025
Bipartisan Support of Bill S 2620
Total Number of Sponsors
4Democrat Sponsors
4Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
1Democrat Cosponsors
0Republican Cosponsors
1Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 2620
Primary Policy Focus
Alternate Title(s) of Bill S 2620
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications.
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications.
Comments
Amaya Jacobs
619
6 months ago
I don't like this bill.
Sponsors and Cosponsors of S 2620
Latest Bills
Homeowner Energy Freedom Act
Bill HR 4758February 18, 2026
Reliable Federal Infrastructure Act
Bill HR 4690February 18, 2026
PETSAFE Act of 2026
Bill HR 7438February 18, 2026
Modernizing and Improving the National Terrorism Advisory System Act of 2026
Bill HR 7448February 18, 2026
Uniform Standards for Federal Law Enforcement Act of 2026
Bill HR 7439February 18, 2026
National Bridge Funding Reform Act
Bill HR 7442February 18, 2026
Protection of Women in Olympic and Amateur Sports Act of 2026
Bill HR 1028February 18, 2026
Disaster Zone Energy Affordability and Investment Act
Bill HR 7450February 18, 2026
Bayard Rustin Stamp Act
Bill HR 7441February 18, 2026
Native American Entrepreneurial Opportunity Act
Bill HR 7396February 18, 2026